InvestorsObserver
×
News Home

Is it Time to Dump Fresenius Medical Care AG & Co. (FMS) Stock After it Is Up 6.70% in a Week?

Tuesday, June 28, 2022 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Fresenius Medical Care AG & Co. (FMS) Stock After it Is Up 6.70% in a Week?

Fresenius Medical Care AG & Co. (FMS) stock is higher by 6.70% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Fresenius Medical Care AG & Co. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on FMS!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With FMS Stock Today?

Fresenius Medical Care AG & Co. (FMS) stock has fallen -1.24% while the S&P 500 is up 0.06% as of 10:41 AM on Tuesday, Jun 28. FMS is down -$0.32 from the previous closing price of $25.47 on volume of 252,359 shares. Over the past year the S&P 500 is lower by -9.05% while FMS is down -39.88%. FMS earned $1.59 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 15.85. To see InvestorsObserver's Sentiment Score for Fresenius Medical Care AG & Co. click here.

More About Fresenius Medical Care AG & Co.

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line. Click Here to get the full Stock Report for Fresenius Medical Care AG & Co. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App